DNA Capital Leads ~USD60m Round for Brazilian Drug Prescription Provider Memed
Source: Brazil Journal
DNA Capital led a ~USD60m round in Memed, a Brazilian provider of digital drug prescriptions, to expand its services from prescriptions to drug fulfillment. DNA Capital led the company’s USD4.5m Series B in April 2020. Read more